Compound HbS or beta thalassaemia heterozygotes (Q66717): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A forma heterozigota (traço falciforme) é quase sempre assintomática, e a única manifestação usual significativa é o defeito da concentração renal manifestando com isostenúria (inclui HbS/compostos delta-beta-tal). | |||
| description / en | description / en | ||
The heterozygous form (sickle cell trait) is almost always asymptomatic, and the only usual significant manifestation is the renal concentrating defect presenting with isosthenuria (includes HbS/delta-beta-thal compounds.) | |||
Revision as of 14:32, 14 August 2026
The heterozygous form (sickle cell trait) is almost always asymptomatic, and the only usual significant manifestation is the renal concentrating defect presenting with isosthenuria (includes HbS/delta-beta-thal compounds.)
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_201007614 |
||
| English | Compound HbS or beta thalassaemia heterozygotes |
The heterozygous form (sickle cell trait) is almost always asymptomatic, and the only usual significant manifestation is the renal concentrating defect presenting with isosthenuria (includes HbS/delta-beta-thal compounds.) |
